OverviewChartTechnicalNewsTraderScreen

iBio Inc/  US4510337086  /

NYSE MKT (Amex)
2024-04-24  10:10:00 PM Chg. 0.0000 Volume Bid10:00:00 AM Ask10:00:00 AM High Low
1.9000USD 0.00% 99,189
Turnover: 167,484.8457		 1.8200Bid Size: 200 1.9500Ask Size: 100 1.9800 1.8302
GlobeNewswire 03-27 iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel ...
GlobeNewswire 03-27 iBio Announces $15.0 Million Private Placement
GlobeNewswire 02-26 iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka
GlobeNewswire 01-30 Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemi...
GlobeNewswire 01-16 iBio Announces Participation in 23rd Annual PepTalk Conference
GlobeNewswire 2023-12-26 iBio Amends and Extends Maturity of Credit Agreement
GlobeNewswire 2023-12-05 iBio, Inc. Announces Pricing of $4.5 Million Public Offering
GlobeNewswire 2023-11-27 iBio Announces Reverse Stock Split
GlobeNewswire 2023-11-15 Impact Biomedical Inc. Files Current Report on Form 8-K
GlobeNewswire 2023-11-01 iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with C...
GlobeNewswire 2023-10-12 DSS Inc. Issues Letter to Shareholders
GlobeNewswire 2023-10-10 iBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of Biologics
GlobeNewswire 2023-10-02 iBio Explains Recent Filing of Registration Statement
GlobeNewswire 2023-09-27 iBio Announces Filing of 2023 Annual Report on SEC Form 10-K
GlobeNewswire 2023-09-21 iBio Announces Amendment to Credit Agreement with Woodforest
GlobeNewswire 2022-03-11 iBio to Participate in the Oppenheimer 32nd Annual Healthcare Conference
GlobeNewswire 2022-02-14 iBio Reports Fiscal Second Quarter 2022 Financial Results and Provides Corporate Update
GlobeNewswire 2022-02-07 iBio to Report Fiscal 2022 Second Quarter Financial Results and Provide Corporate Update on Monday, ...
GlobeNewswire 2022-01-26 iBio Announces Progression of Vaccine Program for Multi-Variant COVID-19 Disease
GlobeNewswire 2022-01-04 iBio Announces Participation in the H.C. Wainwright BioConnect Conference
GlobeNewswire 2021-12-22 iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022
GlobeNewswire 2021-12-21 iBio Provides Information for Listening to the Virtual Annual Stockholder Meeting
GlobeNewswire 2021-12-10 iBio Announces Partial Adjournment of Annual Meeting to December 22
GlobeNewswire 2021-12-09 Victory Square Technologies Provides Corporate Update as at December 9, 2021
GlobeNewswire 2021-11-29 Omicron Variant Underscores Need for New COVID Vaccine Candidates Like IBIO-202